欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/3184/001
药品名称Icatibant Fresenius
活性成分
    • icatibant 30.0 mg
剂型Solution for injection in pre-filled syringe
上市许可持有人Fresenius Kabi AB Rapsgatan 7 751 74 Uppsala Sweden
参考成员国 - 产品名称Denmark (DK)
Icatibant Fresenius
互认成员国 - 产品名称
    • Norway (NO)
      Icatibant Fresenius
    • Finland (FI)
    • Germany (DE)
      Icatibant Fresenius 30 mg/3 ml Injektionslösung in einer Fertigspritze
    • Poland (PL)
      Icatibant Fresenius
    • Belgium (BE)
      Icatibant Fresenius 30 mg oplossing voor injectie in een voorgevulde spuit
    • Latvia (LV)
    • Netherlands (NL)
    • Lithuania (LT)
      Icatibant Fresenius 30 mg injekcinis tirpalas užpildytame švirkšte
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
    • Hungary (HU)
      Icatibant Fresenius 30 mg/3 ml oldatos injekció előretöltött fecskendőben
    • France (FR)
    • Czechia (CZ)
      Icatibant Fresenius
    • Spain (ES)
    • Slovakia (SK)
    • Portugal (PT)
    • Croatia (HR)
    • Italy (IT)
    • United Kingdom (Northern Ireland) (XI)
    • Sweden (SE)
许可日期2021/12/15
最近更新日期2023/05/30
药物ATC编码
    • B06AC02 icatibant
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase